R
Ruth A. McDonald
Researcher at University of Washington
Publications - 64
Citations - 5855
Ruth A. McDonald is an academic researcher from University of Washington. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 34, co-authored 64 publications receiving 5415 citations. Previous affiliations of Ruth A. McDonald include Boston Children's Hospital & Seattle Children's.
Papers
More filters
Journal ArticleDOI
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Bertram L. Kasiske,Martin Zeier,Jeremy R. Chapman,Jonathan C. Craig,Henrik Ekberg,Catherine A. Garvey,Michael Green,Vivekanand Jha,Michelle A. Josephson,Bryce A. Kiberd,Henri Kreis,Ruth A. McDonald,John M. Newmann,Gregorio T. Obrador,Flavio Vincenti,Michael Cheung,Amy Earley,Gowri Raman,Samuel A Abariga,Martin Wagner,Ethan M Balk +20 more
TL;DR: The guideline makes recommendations for immunosuppression and graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy, and other complications that are common in kidney transplant recipients, including hematological and bone disorders.
Journal ArticleDOI
Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).
TL;DR: Since the first data analysis in 1989, NAPRTCS reports have documented marked improvements in outcome after renal transplantation in addition to identifying factors associated with both favorable and poor outcomes.
Journal ArticleDOI
The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
TL;DR: Despite the potential therapies for focal segmental glomerulosclerosis (FSGS), there has been little change in its incidence and this lesion continues to be the most common cause of renal failure and transplantation among acquired diseases.
Journal ArticleDOI
The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome.
Melissa A. Parisi,Craig L. Bennett,Melissa L. Eckert,William B. Dobyns,Joseph G. Gleeson,Dennis W. W. Shaw,Ruth A. McDonald,Allison A. Eddy,Phillip F. Chance,Ian A. Glass +9 more
TL;DR: The NPHP1 deletion represents the first molecular defect associated with JS in a subset of mildly affected subjects, and Cerebellar malformations consistent with the MTS may be relatively common in patients with juvenile N PHP without classic symptoms of JS.
Journal ArticleDOI
Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids
Ruth A. McDonald,Jodi M. Smith,Martin Ho,R. Lindblad,D. Ikle,Paul C. Grimm,Robert J. Wyatt,Mazen Y Arar,D. Liereman,Nancy D. Bridges,William E. Harmon +10 more
TL;DR: The combination of basiliximab, calcineurin inhibitor, sirolimus and steroids resulted in over‐immunosuppression in a high‐risk pediatric population and it is not recommend its use.